IDO1 and breast cancer: Consistent results were obtained in the human HCC cell line SMMC-7721 and the mouse breast cancer cell line 4T1 that IDO1 overexpression inhibited HSV-1 replication, suggesting the universality of our findings (Supplementary Fig. 1a, b).